These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 31318169

  • 1. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1G93A transgenic mouse model.
    Shang HY, Zhang JJ, Fu ZF, Liu YF, Li S, Chen S, Le WD.
    CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE, Rasmussen AL, Bennett W, King A, West AK, Chung RS, Chuah MI.
    J Neuroinflammation; 2014 Mar 23; 11():55. PubMed ID: 24655927
    [Abstract] [Full Text] [Related]

  • 5. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Zhou QM, Zhang JJ, Li S, Chen S, Le WD.
    CNS Neurosci Ther; 2017 May 23; 23(5):375-385. PubMed ID: 28229532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis.
    Granucci EJ, Griciuc A, Mueller KA, Mills AN, Le H, Dios AM, McGinty D, Pereira J, Elmaleh D, Berry JD, Paganoni S, Cudkowicz ME, Tanzi RE, Sadri-Vakili G.
    Sci Rep; 2019 Nov 27; 9(1):17728. PubMed ID: 31776380
    [Abstract] [Full Text] [Related]

  • 9. Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes.
    Lu J, He AX, Jin ZY, Zhang M, Li ZX, Zhou F, Ma L, Jin HM, Wang JY, Shen X.
    Acta Pharmacol Sin; 2024 May 27; 45(5):926-944. PubMed ID: 38286832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS.
    Apolloni S, Caputi F, Pignataro A, Amadio S, Fabbrizio P, Ammassari-Teule M, Volonté C.
    Int J Mol Sci; 2019 Aug 03; 20(15):. PubMed ID: 31382568
    [Abstract] [Full Text] [Related]

  • 13. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 03; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 14. Perineuronal nets are phagocytosed by MMP-9 expressing microglia and astrocytes in the SOD1G93A ALS mouse model.
    Cheung SW, Bhavnani E, Simmons DG, Bellingham MC, Noakes PG.
    Neuropathol Appl Neurobiol; 2024 Jun 03; 50(3):e12982. PubMed ID: 38742276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice.
    Gento-Caro Á, Vilches-Herrando E, García-Morales V, Portillo F, Rodríguez-Bey G, González-Forero D, Moreno-López B.
    Neuropathol Appl Neurobiol; 2021 Dec 03; 47(7):1004-1018. PubMed ID: 33508894
    [Abstract] [Full Text] [Related]

  • 17. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model.
    Anzilotti S, Valsecchi V, Brancaccio P, Guida N, Laudati G, Tedeschi V, Petrozziello T, Frecentese F, Magli E, Hassler B, Cuomo O, Formisano L, Secondo A, Annunziato L, Pignataro G.
    Neurobiol Dis; 2021 Nov 03; 159():105480. PubMed ID: 34411705
    [Abstract] [Full Text] [Related]

  • 18. Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity.
    Raffaele S, Nguyen N, Milanese M, Mannella FC, Boccazzi M, Frumento G, Bonanno G, Abbracchio MP, Bonifacino T, Fumagalli M.
    Br J Pharmacol; 2024 Sep 03; 181(18):3303-3326. PubMed ID: 38751168
    [Abstract] [Full Text] [Related]

  • 19. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D'Ambrosi N, Volonté C.
    Dis Model Mech; 2014 Sep 03; 7(9):1101-9. PubMed ID: 25038061
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
    Seredenina T, Nayernia Z, Sorce S, Maghzal GJ, Filippova A, Ling SC, Basset O, Plastre O, Daali Y, Rushing EJ, Giordana MT, Cleveland DW, Aguzzi A, Stocker R, Krause KH, Jaquet V.
    Free Radic Biol Med; 2016 Aug 03; 97():95-108. PubMed ID: 27212019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.